Angiotensin Type 2 Receptor Stimulation Ameliorates Left Ventricular Fibrosis and Dysfunction via Regulation of Tissue Inhibitor of Matrix Metalloproteinase 1/Matrix Metalloproteinase 9 Axis and Transforming Growth Factor &bgr;1 in the Rat Heart

No abstract is available for this paper.

• Publication year

  2014

• Venue

  HYPERTENSION

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.113.02522PMID 24379181
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression.

  2013cited by this paper
• Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome

  2013cited by this paper
• Direct Angiotensin II Type 2 Receptor Stimulation in N&ohgr;-Nitro-L-Arginine-Methyl Ester–Induced Hypertension: The Effect on Pulse Wave Velocity and Aortic Remodeling

  2012cited by this paper
• A Nonpeptide Angiotensin II Type 2 Receptor Agonist Does Not Attenuate Postmyocardial Infarction Left Ventricular Remodeling in Mice

  2012cited by this paper
• Angiotensin Type 2 Receptor Agonist Compound 21 Reduces Vascular Injury and Myocardial Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats

  2012cited by this paper
• Moderate cardiac‐selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury

  2012cited by this paper
• Non-peptide AT2-receptor agonists.

  2011cited by this paper
• Novel therapeutic targets for the treatment of heart failure

  2011cited by this paper
• Cleaved high molecular weight kininogen, a novel factor in the regulation of matrix metalloproteinases in vascular smooth muscle cells.

  2010cited by this paper
• The angiotensin AT2 receptor in left ventricular hypertrophy

  2010cited by this paper
• Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage

  2009cited by this paper
• The role of proteases in transforming growth factor-beta activation.

  2008cited by this paper
• Review: Role of the augmentation index in hypertension

  2008cited by this paper
• Angiotensin II Type 2 Receptor Stimulation: A Novel Option of Therapeutic Interference With the Renin-Angiotensin System in Myocardial Infarction?

  2008cited by this paper
• Vasoactive peptides in cardiovascular (patho)physiology

  2007cited by this paper
• Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.

  2007cited by this paper
• Mechanisms of Post-Infarct Left Ventricular Remodeling.

  2007influential reference
• Interaction between AT1 and AT2 receptors during postinfarction left ventricular remodeling.

  2006cited by this paper
• Physiology of local renin-angiotensin systems.

  2006cited by this paper
• Fibrosis in heart disease: understanding the role of transforming growth factor‐β1 in cardiomyopathy, valvular disease and arrhythmia

  2006cited by this paper
• Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.

  2004cited by this paper
• Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling

  2003cited by this paper
• Cardioprotective Role of AT2 Receptor in Postinfarction Left Ventricular Remodeling

  2003cited by this paper
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry

  2003cited by this paper
• Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

  2003cited by this paper
• Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice.

  2003influential reference
• Angiotensin II Type 2 Receptor Overexpression Preserves Left Ventricular Function After Myocardial Infarction

  2002cited by this paper
• Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1).

  2002cited by this paper
• Alterations of β-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β1

  2002cited by this paper
• Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice.

  2000cited by this paper
• Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry.

  1999cited by this paper
• Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction.

  1999cited by this paper
• AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction.

  1998cited by this paper
• Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression.

  1998cited by this paper
• A simple method for preparation of cultured cardiac fibroblasts from adult human ventricular tissue

  1997influential reference
• Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.

  1995cited by this paper
• Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.

  1994cited by this paper
• Remodeling and reparation of the cardiovascular system.

  1992cited by this paper

• Novel angiotensin receptor target as therapy for the diabetic heart: the AT2R.

  2025cites this paper
• Advancing antihypertensive drug development

  2025cites this paper
• The angiotensin II type 2 receptor attenuates aging-associated arterial stiffness in female mice.

  2025cites this paper
• Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?

  2024cites this paper
• Angiotensin AT2 receptors reduce inflammation and fibrosis in cardiovascular remodeling.

  2024cites this paper
• Biomarcadores Potenciais na Fibrose Miocárdica: Uma Análise Bioinformática

  2024cites this paper
• Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure.

  2023cites this paper
• Catch your breath: The protective role of the angiotensin AT2 receptor for the treatment of idiopathic pulmonary fibrosis.

  2023cites this paper
• Novel AT2R agonist, β-Pro7Ang III, is cardio- and vaso-protective in diabetic spontaneously hypertensive rats.

  2023cites this paper
• hKLK alleviates myocardial fibrosis in mice with viral myocarditis.

  2023cites this paper
• Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure

  2023cites this paper
• The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target

  2022cites this paper
• Analysis of the molecular mechanism of Huangqi herb treating COVID-19 with myocardial injury by pharmacological tools, programming software and molecular docking.

  2022cites this paper
• Research Progress of Myocardial Fibrosis and Atrial Fibrillation

  2022cites this paper
• Baicalein Ameliorates Myocardial Ischemia Through Reduction of Oxidative Stress, Inflammation and Apoptosis via TLR4/MyD88/MAPKS/NF-κB Pathway and Regulation of Ca2+ Homeostasis by L-type Ca2+ Channels

  2022cites this paper
• Physiological and pathological roles of Ang II and Ang- (1-7) in the female reproductive system

  2022cites this paper
• Pathophysiology and pharmacology of G protein-coupled receptors in the heart.

  2022cites this paper
• The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice

  2022cites this paper
• AT2R stimulation with C21 prevents arterial stiffening and endothelial dysfunction in the abdominal aorta from mice fed a high-fat diet.

  2021cites this paper
• Low-Dose Empagliflozin Improves Systolic Heart Function after Myocardial Infarction in Rats: Regulation of MMP9, NHE1, and SERCA2a

  2021cites this paper
• Angiotensin II Type 2 Receptor

  2021cites this paper
• Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension

  2021cites this paper
• Communication Between Cardiomyocytes and Fibroblasts During Cardiac Ischemia/Reperfusion and Remodeling: Roles of TGF-β, CTGF, the Renin Angiotensin Axis, and Non-coding RNA Molecules

  2021cites this paper
• [6]-Gingerol Ameliorates ISO-induced Myocardial Fibrosis by Reducing Oxidative Stress, Inflammation and Apoptosis Through Inhibition of TLR4/MAPKs/NF-κB Pathway.

  2020cites this paper
• Serelaxin and the AT2 Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan Cilexetil.

  2020cites this paper
• The Other Angiotensin II Receptor: AT2R as a Therapeutic Target.

  2020cites this paper
• The Protective Effects of Compound 21 and Valsartan in Isoproterenol-Induced Myocardial Injury in Rats

  2020cites this paper
• Targeting the Renin-Angiotensin-Aldosterone System in Fibrosis.

  2020cites this paper
• Sex Differences in the Role of the Angiotensin Type 2 Receptor in the Regulation of Blood Pressure

  2019cites this paper
• The renin-angiotensin system: going beyond the classical paradigms

  2019cites this paper
• Counter-regulatory renin–angiotensin system in cardiovascular disease

  2019cites this paper
• Anti‐fibrotic mechanisms of angiotensin AT2‐receptor stimulation

  2019cites this paper
• Balance and circumstance: The renin angiotensin system in wound healing and fibrosis.

  2018cites this paper
• Angiotensin peptides in the non‐gravid uterus: Paracrine actions beyond circulation

  2018cites this paper
• Small‐molecule AT2 receptor agonists

  2018cites this paper
• Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

  2018cites this paper
• AT2R (Angiotensin AT2 Receptor) Agonist, Compound 21, Prevents Abdominal Aortic Aneurysm Progression in the Rat

  2018cites this paper
• Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats

  2018cites this paper
• Ski drives an acute increase in MMP‐9 gene expression and release in primary cardiac myofibroblasts

  2018cites this paper
• Gene therapy for hypertension

  2017cites this paper
• The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders

  2017cites this paper
• Effect of vitamin D intervention on the RAAS system activity and cardiovascular remodeling in spontaneously hypertensive rats

  2017cites this paper
• Shikonin ameliorates isoproterenol (ISO)-induced myocardial damage through suppressing fibrosis, inflammation, apoptosis and ER stress.

  2017cites this paper
• AT2 receptors in cardiovascular and renal diseases

  2017cites this paper
• Protection of flavonoids from Smilax china L. rhizome on phenol mucilage-induced pelvic inflammation in rats by attenuating inflammation and fibrosis

  2017cites this paper
• Anti-fibrotic Potential of AT2 Receptor Agonists

  2017influential citation
• Future drug discovery in renin-angiotensin-aldosterone system intervention

  2017cites this paper
• Angiotensin II type 2 receptor signalling promotes glioblastoma growth : a novel target for therapeutic intervention

  2017cites this paper
• Rapid, Automated, and Specific Immunoassay to Directly Measure Matrix Metalloproteinase-9–Tissue Inhibitor of Metalloproteinase-1 Interactions in Human Plasma Using AlphaLISA Technology: A New Alternative to Classical ELISA

  2017cites this paper
• Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease.

  2016cites this paper
• Investigating Angiotensin II in cardiac remodelling and the counter-regulatory actions of Angiotensin-(1-9)

  2016cites this paper
• The angiotensin II type 2 receptor activates flow-mediated outward remodelling through T cells-dependent interleukin-17 production.

  2016cites this paper
• Angiotensin type-2 (AT-2)-receptor activation reduces renal fibrosis in cyclosporine nephropathy: evidence for blood pressure independent effect

  2016cites this paper
• Long-Term Angiotensin II Receptor Blockade Limits Hypertension, Aortic Dysfunction, and Structural Remodeling in a Rat Model of Chronic Kidney Disease

  2016cites this paper
• MMP9 Rs3918242 Polymorphism Affects Tachycardia-Induced MMP9 Expression in Cultured Atrial-Derived Myocytes but Is Not a Risk Factor for Atrial Fibrillation among the Taiwanese

  2016cites this paper
• cAMP-PKA-CaMKII signaling pathway is involved in aggravated cardiotoxicity during Fuzi and Beimu Combination Treatment of Experimental Pulmonary Hypertension

  2016cites this paper
• The Angiotensin AT 2 Receptor in Myocardial Infarction

  2015cites this paper
• AT2 Receptor Signaling

  2015cites this paper
• Chapter 12 – The Role of the AT2R in Vascular Remodeling

  2015cites this paper
• Matrix Metalloproteinase 9 (MMP-9)

  2015cites this paper
• New Developments in the Pharmacological Treatment of Hypertension: Dead-End or a Glimmer at the Horizon?

  2015cites this paper
• AT 2 Receptor Signaling: Solved and Unsolved

  2015cites this paper
• The AT 2 Receptor: Historical Perspective

  2015cites this paper
• Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia

  2015cites this paper
• Discovery of Nonpeptide, Selective AT 2 Receptor Agonists

  2015cites this paper
• Potential Clinical Application of Angiotensin 2 Receptor Agonists

  2015cites this paper
• Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands.

  2015cites this paper
• The Protective Role of Angiotensin II (AT 2 ) Receptors in Renal Disease: Molecular Mechanisms and Indications for AT2 Agonist Therapy

  2015cites this paper
• Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders

  2015cites this paper
• The Anterior Spreader Flap: A Minimally Invasive Alternative to the Auto Spreader Flap in the Treatment of Patients with Nasal Valve Dysfunction

  2014cites this paper
• Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats.

  2014cites this paper
• Novel Therapeutics in Renal Diseases Prevention of diabetic nephropathy by compound 21 , selective agonist of angiotensin type 2 receptors , in Zucker diabetic fatty rats

  2014cites this paper
• AT2 Receptors Targeting Cardiac Protection Post-Myocardial Infarction

  2014cites this paper
• Dysregulation of Mfn2 and Drp-1 proteins in heart failure.

  2014cites this paper
• Activation of central angiotensin type 2 receptors by compound 21 improves arterial baroreflex sensitivity in rats with heart failure.

  2014cites this paper
• Is angiotensin II type 2 receptor a new therapeutic target for cardiovascular disease?

  2014influential citation
• Clinical Perspectives and Fundamental Aspects of Local Cardiovascular and Renal Renin-Angiotensin Systems

  2014cites this paper
• The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases

  2014cites this paper
• Biomarkers in Trypanosoma cruzi-Infected and Uninfected Individuals with Varying Severity of Cardiomyopathy in Santa Cruz, Bolivia

  2014cites this paper
• N-Aryl Isoleucine Derivatives as Angiotensin II AT2 Receptor Ligands

  2014cites this paper